BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32067426)

  • 1. Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
    Apolinário TA; da Silva IDS; Agostinho LA; Paiva CLA
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1181. PubMed ID: 32067426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
    Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
    J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
    Apolinário TA; Paiva CL; Agostinho LA
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population.
    Semaka A; Kay C; Doty CN; Collins JA; Tam N; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):864-71. PubMed ID: 24038799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
    Kay C; Collins JA; Wright GEB; Baine F; Miedzybrodzka Z; Aminkeng F; Semaka AJ; McDonald C; Davidson M; Madore SJ; Gordon ES; Gerry NP; Cornejo-Olivas M; Squitieri F; Tishkoff S; Greenberg JL; Krause A; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):346-357. PubMed ID: 29460498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (
    De Luca A; Morella A; Consoli F; Fanelli S; Thibert JR; Statt S; Latham GJ; Squitieri F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
    Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
    J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and distribution of polyQ disease intermediate-length repeat alleles in healthy Italian population.
    Mongelli A; Magri S; Salvatore E; Rizzo E; De Rosa A; Fico T; Gatti M; Gellera C; Taroni F; Mariotti C; Nanetti L
    Neurol Sci; 2020 Jun; 41(6):1475-1482. PubMed ID: 31940111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses.
    Chong SS; Almqvist E; Telenius H; LaTray L; Nichol K; Bourdelat-Parks B; Goldberg YP; Haddad BR; Richards F; Sillence D; Greenberg CR; Ives E; Van den Engh G; Hughes MR; Hayden MR
    Hum Mol Genet; 1997 Feb; 6(2):301-9. PubMed ID: 9063751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease.
    Menéndez-González M; Clarimón J; Rosas-Allende I; Blázquez M; San Martín ES; García-Fernández C; Lleó A; Dols-Icardo O; Illán-Gala I; Morís G; Ribacoba R; Álvarez V; Martínez C
    Neurobiol Aging; 2019 Apr; 76():215.e9-215.e14. PubMed ID: 30583877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic background of Huntington disease in Croatia: Molecular analysis of CAG, CCG, and Delta2642 (E2642del) polymorphisms.
    Hećimović S; Klepac N; Vlasić J; Vojta A; Janko D; Skarpa-Prpić I; Canki-Klain N; Marković D; Bozikov J; Relja M; Pavelić K
    Hum Mutat; 2002 Sep; 20(3):233. PubMed ID: 12204002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population.
    Ramírez-García MÁ; Dávila-Ortiz de Montellano DJ; Martínez-Ruano L; Ochoa-Morales A; Romero-Hidalgo S; Zenteno JC; Yescas-Gómez P
    Neurodegener Dis; 2022; 22(1):34-42. PubMed ID: 35926480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
    Savitt D; Jankovic J
    J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology.
    Uhlmann WR; Peñaherrera MS; Robinson WP; Milunsky JM; Nicholson JM; Albin RL
    Am J Med Genet A; 2015 May; 167A(5):1152-60. PubMed ID: 25736541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
    da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
    J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation.
    Costa MDC; Magalhães P; Guimarães L; Maciel P; Sequeiros J; Sousa A
    J Hum Genet; 2006; 51(3):189-195. PubMed ID: 16372132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies.
    Pérez-Oliveira S; Álvarez I; Rosas I; Menendez-González M; Blázquez-Estrada M; Aguilar M; Corte D; Buongiorno M; Molina-Porcel L; Aldecoa I; Martí MJ; Sánchez-Juan P; Infante J; González-Aramburu I; García-González P; Rosende-Roca M; Boada M; Ruiz A; Periñán MT; Macías-García D; Muñoz-Delgado L; Gómez-Garre P; Mir P; Clarimón J; Lleo A; Alcolea D; De la Casa-Fages B; Duarte I; Álvarez V; Pastor P
    Mov Disord; 2022 Sep; 37(9):1841-1849. PubMed ID: 35852957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: "Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.".
    Franklin GL; Meira AT; Camargo CHF; Teive HAG
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1243. PubMed ID: 32253809
    [No Abstract]   [Full Text] [Related]  

  • 19. Missing the pathological expansion in Huntington disease: de novo c.51C>G variant on the expanded allele causing intrafamilial allele dropout.
    Magri S; Nanetti L; Mongelli A; Rizzo E; Taroni F; Mariotti C; Gellera C
    Am J Med Genet A; 2021 Feb; 185(2):397-400. PubMed ID: 33247537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of the
    Apolinário TA; Rodrigues DC; Lemos MB; Antão Paiva CL; Agostinho LA
    Clin Med Res; 2020 Dec; 18(4):145-152. PubMed ID: 32878904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.